The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAJ Bell Regulatory News (AJB)

Share Price Information for AJ Bell (AJB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 336.00
Bid: 337.00
Ask: 337.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.148%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 336.00
AJB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: AJ Bell (AJB): Platform for growth

24 Jan 2019 07:15

Hardman & Co Research Hardman & Co Research: AJ Bell (AJB): Platform for growth 24-Jan-2019 / 07:15 GMT/BST


Hardman & Co Research: Platform for growth

AJ Bell is one of the largest and fastest-growing investment platforms in the UK. It serves both the adviser market and the DIY investor. Having transitioned to updated technology in 2014, it is well placed to ride the growth in the market and pick up disaffected clients from competitor platforms that are only now upgrading. We anticipate strong profit growth on the back of higher revenues and positive operational gearing. The new asset management business should add further momentum, and higher UK savings rates could be the icing on the cake.

Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/platform-for-growth-2/

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.comFollow us on Twitter @HardmanandCo Contact: Jason Streets +44 20 7194 7622 js@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

769003 24-Jan-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
26th May 20232:43 pmRNSDirector/PDMR Shareholding
25th May 20237:00 amRNSInterim Results
15th May 20238:53 amRNSDirector/PDMR Shareholding
28th Apr 20235:14 pmRNSHolding(s) in Company
28th Apr 20234:08 pmRNSConsultancy Agreement
21st Apr 202311:30 amRNSAppointment of Chair
20th Apr 20237:00 amRNSQ2 Trading Update
13th Apr 20233:00 pmRNSDirector/PDMR Shareholding
12th Apr 20238:05 amRNSDirector/PDMR Shareholding
11th Apr 20232:31 pmRNSDirector/PDMR Shareholding
4th Apr 20234:22 pmRNSDirector Declaration
29th Mar 202310:52 amRNSDirector/PDMR Shareholding
15th Mar 202310:48 amRNSDirector/PDMR Shareholding
2nd Mar 202312:01 pmRNSHolding(s) in Company
28th Feb 20232:48 pmRNSIssue of ordinary shares
15th Feb 20232:55 pmRNSDirector/PDMR Shareholding
8th Feb 20233:05 pmRNSResult of AGM
2nd Feb 202311:04 amRNSIssue of ordinary shares
26th Jan 20239:37 amRNSDirector/PDMR Shareholding
24th Jan 20233:16 pmRNSDirector Declaration
24th Jan 20232:32 pmRNSDirector/PDMR Shareholding
23rd Jan 20239:48 amRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSQ1 Trading Update
13th Jan 20232:57 pmRNSDirector/PDMR Shareholding
12th Jan 20239:24 amRNSDirector/PDMR Shareholding
23rd Dec 20221:00 pmRNSBlock Listing Six Monthly Return
20th Dec 20227:43 amRNSDirector/PDMR Shareholding
19th Dec 20228:00 amRNSPublication of Annual Report and Notice of AGM
15th Dec 20222:31 pmRNSIssue of Ordinary Shares & Total Voting Rights
14th Dec 20225:27 pmRNSDirector/PDMR Shareholding
13th Dec 202211:50 amRNSDirector/PDMR Shareholding
12th Dec 202212:24 pmRNSIssue of ordinary shares
5th Dec 20224:05 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:39 pmRNSHolding(s) in Company
1st Dec 20228:43 amRNSBlock Listing Application
1st Dec 20227:00 amRNSFinal Results
29th Nov 20225:38 pmRNSHolding(s) in Company
29th Nov 20225:36 pmRNSHolding(s) in Company
15th Nov 20229:52 amRNSDirector/PDMR Shareholding
15th Nov 20229:39 amRNSNotice of Results
11th Nov 20225:10 pmRNSHolding(s) in Company
20th Oct 20227:00 amRNSYear-end Trading Update
13th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20222:31 pmRNSDirector/PDMR Shareholding
3rd Oct 20228:00 amRNSConsultancy Agreement
29th Sep 20224:45 pmRNSDirector/PDMR Shareholding
27th Sep 20227:00 amRNSBoard Changes
14th Sep 202211:26 amRNSDirector/PDMR Shareholding
9th Sep 20228:20 amRNSDirector/PDMR Shareholding
9th Sep 20228:20 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.